{"id":"enallylpropymal","rwe":[{"pmid":"20048427","year":"2010","title":"Hydrogen-bond motifs in N-monosubstituted derivatives of barbituric acid: 5-allyl-5-isopropyl-1-methylbarbituric acid (enallylpropymal) and 1,5-di(but-2-enyl)-5-ethylbarbituric acid.","finding":"","journal":"Acta crystallographica. Section C, Crystal structure communications","studyType":"Clinical Study"}],"tags":[{"label":"enallylpropymal","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"narconumal","offLabel":[],"synonyms":["narconumal","5-Allyl-5-isopropyl-1-methylbarbituric acid","enallylpropymal"],"timeline":[],"approvals":[],"brandName":"Narconumal","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"enallylpropymal","explanation":"In simple terms, Narconumal is a type of medication that works by interacting with specific molecules in the body to produce a desired effect. However, without more information, it's difficult to explain exactly how it works. More research is needed to understand its mechanism of action.","oneSentence":"Unfortunately, the mechanism of action of Narconumal is not well-documented.","technicalDetail":"Narconumal's mechanism of action is not well-documented, but it is classified as a small molecule drug of the enallylpropymal class."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3448","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=enallylpropymal","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:59:37.542263","biosimilars":[],"competitors":[],"genericName":"enallylpropymal","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"17BT2X209M","CHEBI":"CHEBI:134920","UMLSCUI":"C2745414","PUBCHEM_CID":"95636","MESH_SUPPLEMENTAL_RECORD_UI":"C547121"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":1,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"2010 Jan","pmid":"20048427","title":"Hydrogen-bond motifs in N-monosubstituted derivatives of barbituric acid: 5-allyl-5-isopropyl-1-methylbarbituric acid (enallylpropymal) and 1,5-di(but-2-enyl)-5-ethylbarbituric acid.","journal":"Acta crystallographica. Section C, Crystal structure communications"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Narconumal (enallylpropymal) is a small molecule drug of the enallylpropymal class, but information on its target and mechanism of action is not available. Its commercial status, including patent status and generic availability, is also unknown. Narconumal's approved indications, half-life, and bioavailability are not documented. As a result, key safety considerations and pharmacological details are also unclear. Further research is necessary to understand Narconumal's properties and clinical applications.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}